# Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

> **NCT00785044** · — · COMPLETED · sponsor: **GE Healthcare** · enrollment: 471 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** I-123 mIBG

## Key facts

- **NCT ID:** NCT00785044
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 471 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785044, "Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00785044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*